|
|
Article: Company Profile for Bay City Capital LLC.
- Article from:
- Business Wire
- Article date:
- March 13, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Bay City Capital is a venture capital firm specializing in life sciences with $1.5 billion in capital commitments. Bay City Capital pursues a broad spectrum of investment opportunities across the various life sciences sectors and with companies at all stages of development. Bay City Capital's portfolio includes companies focusing on biopharmaceuticals and drug discovery, as well as medical devices and diagnostics, with investments ranging from seed investing to early, mid-, and late-stage, as well as select public investing.
Company:
Related newspaper, magazine, and journal articles:
|
|
Article: Bay City Capital Increases NeoRx Ownership.
Business Wire;
March 1, 1999 ;
700+ words
... ... NERX) today announced that The Bay City Capital Fund I, L.P. has purchased ... the company. Its affiliate, Bay City Capital LLC, is a merchant banking ... is a Managing Director of Bay City Capital LLC. "We believe in the technologies ...
|
|